These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 28007903)

  • 1. Autophagy activators suppress cystogenesis in an autosomal dominant polycystic kidney disease model.
    Zhu P; Sieben CJ; Xu X; Harris PC; Lin X
    Hum Mol Genet; 2017 Jan; 26(1):158-172. PubMed ID: 28007903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney Disease.
    Weisser I; Eckberg K; D'Amico S; Buttram D; Aboudehen K
    J Am Soc Nephrol; 2024 Jan; 35(1):41-55. PubMed ID: 37953472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
    Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin-mediated suppression of renal cyst expansion in del34 Pkd1-/- mutant mouse embryos: an investigation of the feasibility of renal cyst prevention in the foetus.
    Stayner C; Shields J; Slobbe L; Shillingford JM; Weimbs T; Eccles MR
    Nephrology (Carlton); 2012 Nov; 17(8):739-47. PubMed ID: 22725947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.
    Li A; Fan S; Xu Y; Meng J; Shen X; Mao J; Zhang L; Zhang X; Moeckel G; Wu D; Wu G; Liang C
    J Cell Mol Med; 2017 Aug; 21(8):1619-1635. PubMed ID: 28244683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of folate-conjugated rapamycin versus unconjugated rapamycin in an orthologous mouse model of polycystic kidney disease.
    Kipp KR; Kruger SL; Schimmel MF; Parker N; Shillingford JM; Leamon CP; Weimbs T
    Am J Physiol Renal Physiol; 2018 Aug; 315(2):F395-F405. PubMed ID: 29717938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early treatment with 2-deoxy-d-glucose reduces proliferative proteins in the kidney and slows cyst growth in a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease (PKD).
    Atwood D; He Z; Miyazaki M; Hailu F; Klawitter J; Edelstein CL
    Cell Signal; 2024 Nov; 123():111351. PubMed ID: 39159908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased mTOR and suppressed autophagic flux in the heart of a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease.
    Atwood DJ; Pokhrel D; Brown CN; Holditch SJ; Bachu DM; Thorburn A; Hopp K; Edelstein CL
    Cell Signal; 2020 Oct; 74():109730. PubMed ID: 32730856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.
    de Stephanis L; Bonon A; Varani K; Lanza G; Gafà R; Pinton P; Pema M; Somlo S; Boletta A; Aguiari G
    Clin Exp Nephrol; 2017 Apr; 21(2):203-211. PubMed ID: 27278932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of sirolimus and mTOR kinase inhibitor in a hypomorphic
    Holditch SJ; Brown CN; Atwood DJ; Lombardi AM; Nguyen KN; Toll HW; Hopp K; Edelstein CL
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F187-F196. PubMed ID: 31042058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
    Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
    Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease.
    Qin S; Taglienti M; Nauli SM; Contrino L; Takakura A; Zhou J; Kreidberg JA
    J Clin Invest; 2010 Oct; 120(10):3617-28. PubMed ID: 20852388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibition of MDM2 slows cell proliferation and activates apoptosis in ADPKD cell lines.
    Patergnani S; Giattino A; Bianchi N; Giorgi C; Pinton P; Aguiari G
    Biol Cell; 2023 Jan; 115(1):e2200037. PubMed ID: 36165233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA
    Aboudehen K; Farahani S; Kanchwala M; Chan SC; Avdulov S; Mickelson A; Lee D; Gearhart MD; Patel V; Xing C; Igarashi P
    J Biol Chem; 2018 Jun; 293(24):9388-9398. PubMed ID: 29716997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.
    Li LX; Fan LX; Zhou JX; Grantham JJ; Calvet JP; Sage J; Li X
    J Clin Invest; 2017 Jun; 127(7):2751-2764. PubMed ID: 28604386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulatory 1α subunit of protein kinase A modulates renal cystogenesis.
    Ye H; Wang X; Constans MM; Sussman CR; Chebib FT; Irazabal MV; Young WF; Harris PC; Kirschner LS; Torres VE
    Am J Physiol Renal Physiol; 2017 Sep; 313(3):F677-F686. PubMed ID: 28615245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of accelerated renal cystogenesis in Pkd1 mice by renin-angiotensin system blockade.
    Fitzgibbon WR; Dang Y; Bunni MA; Baicu CF; Zile MR; Mullick AE; Saigusa T
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F210-F218. PubMed ID: 29021226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
    Chen L; Zhou X; Fan LX; Yao Y; Swenson-Fields KI; Gadjeva M; Wallace DP; Peters DJ; Yu A; Grantham JJ; Li X
    J Clin Invest; 2015 Jun; 125(6):2399-412. PubMed ID: 25961459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease.
    Zafar I; Ravichandran K; Belibi FA; Doctor RB; Edelstein CL
    Kidney Int; 2010 Oct; 78(8):754-61. PubMed ID: 20686448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation.
    Nishio S; Hatano M; Nagata M; Horie S; Koike T; Tokuhisa T; Mochizuki T
    J Clin Invest; 2005 Apr; 115(4):910-8. PubMed ID: 15761494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.